Osurnia Otic Gel for canine ear inflammation now available from Dechra

[note note_color=”#FFFF66″ text_color=”#333333″ radius=”3″]Correction made on August 4, 2020 at 4:30 PM EST regarding the administration of the product.[/note]

Dechra Veterinary Products announced the addition of Osurnia Otic Gel to its treatment line for otitis externa. This follows the company’s acquisition of the worldwide manufacturing and marketing rights from Elanco Animal Health.

Otitis externa is inflammation of the external ear canal. It can cause redness and swelling in dogs, and behaviors like head shaking and scratching.

Osurnia Otic Gel is indicated for otitis externa associated with susceptible strains of bacteria (Staphylococcus pseudintermedius) and yeast (Malassezia pachydermatis). It contains three active ingredients: florfenicol (antibacterial), terbanifine (antifungal) and a glucocorticosteroid: betamethasone acetate (inflammation and pain reliever).

The product comes as a gel, which spreads through the ear canal and is also maintained at the infection site, according to Dechra. It should be administered at the clinic. One dose (a tube) is administered per affected ear and repeat administration in seven days. It’s the same dose for any dog, regardless of size and weight.

Osurnia Otic Gel is now available for veterinarians through select distributors.

“We understand otitis externa is a common challenge for both veterinarians and clients, with ear infections among the most frequent reasons dogs are taken to the veterinarian,” said Mike Eldred, president of Dechra’s North America operations. “Dechra is excited to add Osurnia Otic Gel to our dermatology portfolio and expand our solutions for veterinarians to manage canine otitis.”